Showing 2071-2080 of 9963 results for "".
Two Launches from Cutera, AmSpa Projections
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-two-launches-from-cutera-amspa-projections/18356/Cutera introduces two new devices to its laser and energy-based device offerings: Juliet laser represents Cutera's first entry into the women's health segment of the aesthetics market; Secret RF is a new fractional radio frequency microneedling device that effectively remodels collagen, improves milNRS: New Rosacea Classification; Pediatric Teledermatology; Bleach Baths
https://practicaldermatology.com/series/dermwire-tv/nrs-new-rosacea-classification-pediatric-teledermatology-bleach-baths/18394/There's a new standard classification and pathophysiology of rosacea from the National Rosacea Society. New evidence shows that virtual diagnosis of pediatric dermatologic conditions is feasible. New research suggests that water baths may be just as good as bleach baths for treating eczema. ResearchHad Your Fill?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/had-your-fill/18531/If the US filler market seems robust, you should see what's available outside the US, says Hassan Galadari, MD. He provides a global perspective on fillers with a focus on up-and-coming products, the importance of understanding anatomy, and advances in recognizing and treating complications.Mentors in Dermatology
https://practicaldermatology.com/topics/practice-management/mentors-in-dermatology/18719/Neal Bhatia, MD sat down with one of his mentees, Al Damavandy, MD, to discuss what makes a great mentee-mentor relationship and how both parties can benefit. Dr. Damavandy, now a practicing Mohs Surgeon and Dermatologist, shared tips for how to find the right mentor and what he learned from his menPearls from NYC: Oy Vey!
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pearls-from-nyc-oy-vey-/18752/By Gary Goldenberg, MD and Seemal R. Desai, MDWhat happens if you shave a melanoma? Dr. Goldenberg addresses a common question from the clinic. The good news? The type of biopsy done does not appear to affect long-term survival in melanoma.Getting the Upper Hand on NMSC
https://practicaldermatology.com/topics/skin-cancer-photoprotection/getting-the-upper-hand-on-nmsc/18758/By Seemal R. Desai, MD and Anthony Rossi, MDDecide what type of treatment to use to treat the specific, biopsy-confirmed presentation, says Dr. Rossi. He shares tips to optimize topical treatment outcomes in non-melanoma skin cancer.Where is Dermatology Headed?
https://practicaldermatology.com/topics/psoriasis/where-is-dermatology-headed/18590/Neal Bhatia, MD and Joel Schlessinger, MD sit down as the medical editors of Practical Dermatology® to discuss the future of dermatology in this episode of Derm Insider. They talk about how an increased focus on research in the last few years is leading to new treatments and new understanding aboutHow Do You Manage the Aesthetic Patient?
https://practicaldermatology.com/topics/practice-management/how-do-you-manage-the-aesthetic-patient/18775/Managing the aesthetic patient is all about building relationships explains Joel L. Cohen, MD, founder of AboutSkin Dermatology in Englewood, CO. Dr. Cohen speaks with host Adam Friedman, MD, Associate Professor of Dermatology, Director, Residency Program, and Director, Translational Research at TheNew Treatment Algorithms for Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-treatment-algorithms-for-actinic-keratoses/18812/Gary Goldenberg, MD reviews the literature showing why all actinic keratoses (AKs) need to be treated and why it's important to treat the field and not just the visible lesions. He shares his evidence-based, time-sequential therapy approach to combining a destructive modality with field therapy to pLong-Term Effects of Neuromodulators on Aging
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/long-term-effects-of-neuromodulators-on-aging/18810/Shannon Humphrey, MD discusses the cumulative anti-aging benefits of long-term treatments with botulinum toxin type A. She shares her observations from the bench and offers a review of what the literature shows to support her recommendation for regular conservative neuromodulator treatments to impro